Catalyst Wire Dossier Catalyst Wire Dossier

Luveniq

voclosporin · Lux Biosciences GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Luveniq, covering 2011-10-18 to 2011-10-24. Get the full timeline:

Most recent: EMA Application withdrawn: Luveniq (voclosporin) — Lux Biosciences GmbH

See pricing